Compare III & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | III | APYX |
|---|---|---|
| Founded | 2006 | 1982 |
| Country | United States | United States |
| Employees | 1500 | N/A |
| Industry | Professional Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 193.7M | 196.4M |
| IPO Year | 2006 | 1995 |
| Metric | III | APYX |
|---|---|---|
| Price | $4.13 | $3.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $5.50 | ★ $6.50 |
| AVG Volume (30 Days) | ★ 195.4K | 71.6K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.46% | N/A |
| EPS Growth | ★ 216.67 | 19.40 |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $192,745,000.00 | N/A |
| Revenue This Year | $3.85 | $11.93 |
| Revenue Next Year | $4.34 | $11.01 |
| P/E Ratio | $80.30 | ★ N/A |
| Revenue Growth | ★ 4.51 | N/A |
| 52 Week Low | $3.74 | $1.59 |
| 52 Week High | $6.45 | $5.08 |
| Indicator | III | APYX |
|---|---|---|
| Relative Strength Index (RSI) | 54.57 | 40.40 |
| Support Level | $3.88 | $3.31 |
| Resistance Level | $4.33 | $4.18 |
| Average True Range (ATR) | 0.15 | 0.23 |
| MACD | 0.01 | -0.06 |
| Stochastic Oscillator | 81.72 | 0.00 |
Information Services Group Inc is an AI-centered technology research and advisory firm providing digital transformation and technology advisory services that help organizations optimize performance, reduce costs, and accelerate innovation. The Company's expertise includes sourcing advisory, cloud and data analytics, managed governance and risk services, network and software advisory, technology strategy and operations design, change management, and market intelligence, serving both private- and public-sector clients globally. It operates in one segment, fact-based sourcing advisory services, and operates principally in the Americas, with generate maximum revenue in Europe and the Asia Pacific.
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.